Payment overview · 2025
General Payments
$14.23
1 reported records · 1 companies
Healthcare provider profile · identity verified
Jonathan Robert Beers, DO
Allopathic & Osteopathic Physicians|Internal Medicine · ROLLA, MO · NPI 1477783686
Verified facts
What the public records show
CMS Open Payments records show Jonathan Robert Beers, DO received $14.23 in general payments during 2025 across 1 reported records.
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Unresolved — no canonical attribution shown | $14.23 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $14.23 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| LifeVest Normalized: lifevest |
Device | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $14.23 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
None of this doctor’s payer companies has same-entity product evidence that passes the publication threshold. The site does not infer company ownership, affiliates, or generic manufacturers.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Eliquis | Apixaban | 551 | 46 |
| Atorvastatin Calcium | Atorvastatin Calcium | 428 | 68 |
| Furosemide | Furosemide | 425 | 73 |
| Potassium Chloride | Potassium Chloride | 383 | 61 |
| Lisinopril | Lisinopril | 320 | 45 |
| Levothyroxine Sodium | Levothyroxine Sodium | 302 | 37 |
| Pantoprazole Sodium | Pantoprazole Sodium | 301 | 45 |
| Tamsulosin Hcl | Tamsulosin Hcl | 282 | 38 |
| Gabapentin | Gabapentin | 273 | 41 |
| Buspirone Hcl | Buspirone Hcl | 191 | 23 |
| Quetiapine Fumarate | Quetiapine Fumarate | 191 | 24 |
| Xarelto | Rivaroxaban | 187 | 13 |
| Trazodone Hcl | Trazodone Hcl | 186 | 28 |
| Clopidogrel | Clopidogrel Bisulfate | 185 | 43 |
| Tramadol Hcl | Tramadol Hcl | 182 | 31 |
| Sertraline Hcl | Sertraline Hcl | 176 | 22 |
| Mirtazapine | Mirtazapine | 167 | 26 |
| Donepezil Hcl | Donepezil Hcl | 160 | 21 |
| Amlodipine Besylate | Amlodipine Besylate | 150 | 38 |
| Metoprolol Tartrate | Metoprolol Tartrate | 147 | 25 |
| Fluoxetine Hcl | Fluoxetine Hcl | 142 | 18 |
| Metoprolol Succinate | Metoprolol Succinate | 131 | 25 |
| Olanzapine | Olanzapine | 126 | 18 |
| Metformin Hcl | Metformin Hcl | 114 | 18 |
| Alprazolam | Alprazolam | 110 | 19 |
| Citalopram Hbr | Citalopram Hydrobromide | 104 | 14 |
| Carvedilol | Carvedilol | 103 | 18 |
| Escitalopram Oxalate | Escitalopram Oxalate | 99 | 14 |
| Ropinirole Hcl | Ropinirole Hcl | 99 | 11 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 96 | 35 |
| Sucralfate | Sucralfate | 95 | suppressed |
| Duloxetine Hcl | Duloxetine Hcl | 93 | 14 |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 91 | 19 |
| Prednisone | Prednisone | 90 | 43 |
| Losartan Potassium | Losartan Potassium | 88 | 15 |
| Levetiracetam | Levetiracetam | 87 | 14 |
| Memantine Hcl | Memantine Hcl | 78 | 12 |
| Simvastatin | Simvastatin | 78 | 11 |
| Fluticasone Propionate | Fluticasone Propionate | 76 | 25 |
| Clonazepam | Clonazepam | 74 | suppressed |
| Hydrochlorothiazide | Hydrochlorothiazide | 69 | suppressed |
| Nystop | Nystatin | 67 | 34 |
| Venlafaxine Hcl | Venlafaxine Hcl | 63 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 62 | 11 |
| Jardiance | Empagliflozin | 61 | 12 |
| Medroxyprogesterone Acetate | Medroxyprogesterone Acetate | 61 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 61 | suppressed |
| Omeprazole | Omeprazole | 61 | 14 |
| Cefdinir | Cefdinir | 59 | 55 |
| Finasteride | Finasteride | 58 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 58 | 21 |
| Meloxicam | Meloxicam | 58 | suppressed |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 58 | suppressed |
| Permethrin | Permethrin | 57 | 47 |
| Lorazepam | Lorazepam | 56 | 20 |
| Oxybutynin Chloride | Oxybutynin Chloride | 56 | suppressed |
| Januvia | Sitagliptin Phosphate | 52 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 51 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 50 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 50 | suppressed |
| Myrbetriq | Mirabegron | 50 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 47 | 11 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 46 | 35 |
| Baclofen | Baclofen | 46 | suppressed |
| Bumetanide | Bumetanide | 46 | suppressed |
| Celecoxib | Celecoxib | 46 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 44 | 36 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 42 | 12 |
| Humalog | Insulin Lispro | 41 | suppressed |
| Allopurinol | Allopurinol | 40 | suppressed |
| Aripiprazole | Aripiprazole | 40 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 40 | 22 |
| Topiramate | Topiramate | 40 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 38 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 38 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 37 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 37 | 25 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 37 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 36 | 15 |
| Spironolactone | Spironolactone | 36 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 35 | suppressed |
| Glipizide | Glipizide | 35 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 35 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 33 | 29 |
| Cephalexin | Cephalexin | 32 | 26 |
| Doxazosin Mesylate | Doxazosin Mesylate | 32 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 32 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 32 | suppressed |
| Levofloxacin | Levofloxacin | 32 | 29 |
| Midodrine Hcl | Midodrine Hcl | 32 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 32 | suppressed |
| Lidocaine Hcl Viscous | Lidocaine Hcl | 30 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 30 | 12 |
| Trospium Chloride | Trospium Chloride | 30 | suppressed |
| Dilt-Xr | Diltiazem Hcl | 29 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 29 | suppressed |
| Ondansetron Odt | Ondansetron | 29 | 18 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 28 | suppressed |
| Nystatin | Nystatin | 27 | 21 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 27 | suppressed |
| Primidone | Primidone | 26 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 25 | 20 |
| Lactulose | Lactulose | 25 | suppressed |
| Lamotrigine | Lamotrigine | 25 | suppressed |
| Lidocaine | Lidocaine | 25 | suppressed |
| Pregabalin | Pregabalin | 25 | suppressed |
| Risperidone | Risperidone | 25 | suppressed |
| Methylprednisolone | Methylprednisolone | 24 | 21 |
| Fiasp Flextouch | Insulin Aspart (Niacinamide) | 23 | suppressed |
| Insulin Lispro | Insulin Lispro | 23 | 12 |
| Sodium Chloride | 0.9 % Sodium Chloride | 23 | suppressed |
| Colchicine | Colchicine | 22 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 21 | 12 |
| Latanoprost | Latanoprost | 21 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 21 | 17 |
| Carbamazepine | Carbamazepine | 20 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 20 | suppressed |
| Fentanyl | Fentanyl | 20 | suppressed |
| Flecainide Acetate | Flecainide Acetate | 20 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 19 | suppressed |
| Amoxicillin | Amoxicillin | 19 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 19 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 19 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 19 | suppressed |
| Ozempic | Semaglutide | 19 | suppressed |
| Rexulti | Brexpiprazole | 19 | suppressed |
| Haloperidol | Haloperidol | 18 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 18 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 18 | suppressed |
| Brilinta | Ticagrelor | 17 | suppressed |
| Chlorpromazine Hcl | Chlorpromazine Hcl | 17 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 17 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 16 | suppressed |
| Entresto | Sacubitril/Valsartan | 16 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 16 | suppressed |
| Insulin Aspart | Insulin Aspart | 16 | suppressed |
| Lubiprostone | Lubiprostone | 16 | suppressed |
| Belsomra | Suvorexant | 15 | suppressed |
| Bupropion Xl | Bupropion Hcl | 15 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 15 | suppressed |
| Famotidine | Famotidine | 15 | suppressed |
| Haloperidol Lactate | Haloperidol Lactate | 15 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 15 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 15 | suppressed |
| Ivermectin | Ivermectin | 15 | 11 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 15 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 15 | suppressed |
| Verapamil Er | Verapamil Hcl | 15 | suppressed |
| Acyclovir | Acyclovir | 14 | suppressed |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 14 | suppressed |
| Janumet Xr | Sitagliptin Phos/Metformin Hcl | 14 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 14 | suppressed |
| Atenolol | Atenolol | 13 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 13 | suppressed |
| Glimepiride | Glimepiride | 13 | suppressed |
| Invega Sustenna | Paliperidone Palmitate | 13 | suppressed |
| Lovastatin | Lovastatin | 13 | suppressed |
| Novolog | Insulin Aspart | 13 | suppressed |
| Olanzapine Odt | Olanzapine | 13 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 12 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 12 | suppressed |
| Ezetimibe | Ezetimibe | 12 | suppressed |
| Fenofibrate | Fenofibrate | 12 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 12 | suppressed |
| Irbesartan-Hydrochlorothiazide | Irbesartan/Hydrochlorothiazide | 12 | suppressed |
| Ketorolac Tromethamine | Ketorolac Tromethamine | 12 | suppressed |
| Methocarbamol | Methocarbamol | 12 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 12 | suppressed |
| Santyl | Collagenase Clostridium Hist. | 12 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 11 | suppressed |
| Fluconazole | Fluconazole | 11 | suppressed |
| Gemfibrozil | Gemfibrozil | 11 | suppressed |
| Haloperidol Decanoate | Haloperidol Decanoate | 11 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 11 | suppressed |
| Levemir | Insulin Detemir | 11 | suppressed |
| Linzess | Linaclotide | 11 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 11 | suppressed |
| Paliperidone Er | Paliperidone | 11 | suppressed |
| Quetiapine Fumarate Er | Quetiapine Fumarate | 11 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 11 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $14.23 · 1 records | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error